Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Reset all filters
01 4sanofi-aventis Canada Inc.
02 3Abbott Laboratories Limited
03 2PENDOPHARM, Division of Pharmascience Inc.
Reset all filters
01 32036089
02 22362769
03 42436275
Reset all filters
01 2LEUPROLIDE ACETATE
02 7Leuprolide Acetate
Reset all filters
01 2POWDER FOR SUSPENSION
02 3Powder for Injection
03 3Powder for Suspension, Sustained-Release
04 1Solution for Injection
Reset all filters
01 32011-02-11
02 22020-12-15
03 42021-09-21
Patent Expiration Date : 2021-09-21
Date Granted : 2007-01-02
Brand Name : ELIGARD
Patent Number : 2436275
Filing Date : 2001-09-21
Strength per Unit : 7.5mg
Dosage Form : Solution for Injection
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2021-09-21
Date Granted : 2007-01-02
Patent Expiration Date : 2021-09-21
Date Granted : 2007-01-02
Brand Name : ELIGARD
Patent Number : 2436275
Filing Date : 2001-09-21
Strength per Unit : 22.5 mg / syringe
Dosage Form : Powder for Suspension, Sustained-Release
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2021-09-21
Date Granted : 2007-01-02
Patent Expiration Date : 2021-09-21
Date Granted : 2007-01-02
Brand Name : ELIGARD
Patent Number : 2436275
Filing Date : 2001-09-21
Strength per Unit : 30 mg / syringe
Dosage Form : Powder for Suspension, Sustained-Release
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2021-09-21
Date Granted : 2007-01-02
Patent Expiration Date : 2021-09-21
Date Granted : 2007-01-02
Brand Name : ELIGARD
Patent Number : 2436275
Filing Date : 2001-09-21
Strength per Unit : 45 mg / syringe
Dosage Form : Powder for Suspension, Sustained-Release
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2021-09-21
Date Granted : 2007-01-02
Patent Expiration Date : 2011-02-11
Date Granted : 2000-12-05
Brand Name : LUPRON DEPOT
Patent Number : 2036089
Filing Date : 1991-02-11
Strength per Unit : 30 mg
Dosage Form : Powder for Injection
Human Or VET : Human
Route of Administration : Intramuscular
Patent Expiration Date : 2011-02-11
Date Granted : 2000-12-05
Patent Expiration Date : 2011-02-11
Date Granted : 2000-12-05
Brand Name : LUPRON DEPOT
Patent Number : 2036089
Filing Date : 1991-02-11
Strength per Unit : 11.25mg
Dosage Form : Powder for Injection
Human Or VET : Human
Route of Administration : Intramuscular
Patent Expiration Date : 2011-02-11
Date Granted : 2000-12-05
Patent Expiration Date : 2011-02-11
Date Granted : 2000-12-05
Brand Name : LUPRON DEPOT
Patent Number : 2036089
Filing Date : 1991-02-11
Strength per Unit : 22.5mg
Dosage Form : Powder for Injection
Human Or VET : Human
Route of Administration : Intramuscular
Patent Expiration Date : 2011-02-11
Date Granted : 2000-12-05
Patent Expiration Date : 2020-12-15
Date Granted : 2008-09-09
Brand Name : ZEULIDE DEPOT
Patent Number : 2362769
Filing Date : 2000-12-15
Strength per Unit : 3.75 mg
Dosage Form : POWDER FOR SUSPENSION
Human Or VET : Human
Route of Administration : INTRAMUSCULAR
Patent Expiration Date : 2020-12-15
Date Granted : 2008-09-09
Patent Expiration Date : 2020-12-15
Date Granted : 2008-09-09
Brand Name : ZEULIDE DEPOT
Patent Number : 2362769
Filing Date : 2000-12-15
Strength per Unit : 22.5 mg
Dosage Form : POWDER FOR SUSPENSION
Human Or VET : Human
Route of Administration : INTRAMUSCULAR
Patent Expiration Date : 2020-12-15
Date Granted : 2008-09-09
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF